Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Sureda

Showing results (41-50 of 380) with videos related to

Pageof 38
Sort By:
Mycoses|March 31, 2016
Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?Helena Pomares, Montserrat Arnan, Isabel Sánchez-Ortega, et al.
Clinical Advances in Hematology & Oncology : H&O|June 22, 2022
Follicular lymphoma grade 3: a comprehensive reviewAlfadel Alshaibani, Riad El Fakih, Anna Sureda, et al.
Bone Marrow Transplantation|September 30, 2021
Visions for a JACIE Quality Management System 4.0John A Snowden, Eoin McGrath, Kim Orchard, et al.
Bone Marrow Transplantation|December 14, 2024
Anti-CD19 CAR T-cell therapy for primary and secondary CNS lymphomasGiulia Losi, Alberto Mussetti, Marta Peña, et al.
Medicina Clinica|July 5, 2016
[Mobilization of peripheral blood stem cells with plerixafor in poor mobilizer patients]Juan-Manuel Sancho, Rafael Duarte, Laura Medina, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2020
Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-Engineered T Cell Era: Still a Role for Allogeneic Transplantation?Peter Dreger, Timothy S Fenske, Silvia Montoto, et al.
Clinical Nutrition ESPEN|July 6, 2024
Modern views of nutritional support in patients undergoing allogeneic stem cell transplantationAnnalisa Paviglianiti, Antonio Bianchessi, Daniele Avenoso, et al.
Bone Marrow Transplantation|June 10, 2018
High-dose therapy with BEAC conditioning compared to BEAM conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: no differences in toxicity or outcome. A matched-control study of the EBMT-Lymphoma Working PartyStephen Paul Robinson, Ariane Boumendil, Herve Finel, et al.
Frontiers in Nephrology|May 6, 2024
CAR T-cell therapy and the onco-nephrologistMarco Aurelio Salvino, Alberto Mussetti, Marta Peña, et al.
The Lancet. Haematology|April 5, 2020
Handling the COVID-19 pandemic in the oncological settingAlberto Mussetti, Clara Maluquer, Adaia Albasanz-Puig, et al.
Pageof 38

Showing results (41-50 of 380) with videos related to

Sort By:
Pageof 38
Mycoses|March 31, 2016
Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?Helena Pomares, Montserrat Arnan, Isabel Sánchez-Ortega, et al.
Clinical Advances in Hematology & Oncology : H&O|June 22, 2022
Follicular lymphoma grade 3: a comprehensive reviewAlfadel Alshaibani, Riad El Fakih, Anna Sureda, et al.
Bone Marrow Transplantation|September 30, 2021
Visions for a JACIE Quality Management System 4.0John A Snowden, Eoin McGrath, Kim Orchard, et al.
Bone Marrow Transplantation|December 14, 2024
Anti-CD19 CAR T-cell therapy for primary and secondary CNS lymphomasGiulia Losi, Alberto Mussetti, Marta Peña, et al.
Medicina Clinica|July 5, 2016
[Mobilization of peripheral blood stem cells with plerixafor in poor mobilizer patients]Juan-Manuel Sancho, Rafael Duarte, Laura Medina, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2020
Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-Engineered T Cell Era: Still a Role for Allogeneic Transplantation?Peter Dreger, Timothy S Fenske, Silvia Montoto, et al.
Clinical Nutrition ESPEN|July 6, 2024
Modern views of nutritional support in patients undergoing allogeneic stem cell transplantationAnnalisa Paviglianiti, Antonio Bianchessi, Daniele Avenoso, et al.
Bone Marrow Transplantation|June 10, 2018
High-dose therapy with BEAC conditioning compared to BEAM conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: no differences in toxicity or outcome. A matched-control study of the EBMT-Lymphoma Working PartyStephen Paul Robinson, Ariane Boumendil, Herve Finel, et al.
Frontiers in Nephrology|May 6, 2024
CAR T-cell therapy and the onco-nephrologistMarco Aurelio Salvino, Alberto Mussetti, Marta Peña, et al.
The Lancet. Haematology|April 5, 2020
Handling the COVID-19 pandemic in the oncological settingAlberto Mussetti, Clara Maluquer, Adaia Albasanz-Puig, et al.
Pageof 38